{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:02:31Z","timestamp":1785801751505,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":716,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202040433"],"award-info":[{"award-number":["202040433"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR2036B"],"award-info":[{"award-number":["SHDC2020CR2036B"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jvsv.2022.09.015","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T19:33:46Z","timestamp":1667244826000},"page":"397-403.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-0842","authenticated-orcid":false,"given":"Hongyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-1367","authenticated-orcid":false,"given":"Xiaoxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2022.09.015_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006534-198203000-00002","article-title":"Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics","volume":"69","author":"Mulliken","year":"1982","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jvsv.2022.09.015_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0945-053X(01)00150-0","article-title":"Molecular genetics of vascular malformations","volume":"20","author":"Vikkula","year":"2001","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0041-1729743","article-title":"Management of venous malformations","volume":"38","author":"Acord","year":"2021","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0268355520946211","article-title":"Localized intravascular coagulation in venous malformations: a system review","volume":"36","author":"Han","year":"2021","journal-title":"Phlebology"},{"key":"10.1016\/j.jvsv.2022.09.015_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.144.7.873","article-title":"Association of localized intravascular coagulopathy with venous malformations","volume":"144","author":"Dompmartin","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archderm.144.7.861","article-title":"Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients","volume":"144","author":"Mazoyer","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0268355520972918","article-title":"Venous malformations: coagulopathy control and treatment methods","volume":"36","author":"Budge","year":"2021","journal-title":"Phlebology"},{"key":"10.1016\/j.jvsv.2022.09.015_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.wneu.2019.05.089","article-title":"Repeated intracranial hemorrhage after delivery induced by coagulopathy associated with multiple venous malformations","volume":"128","author":"Tsukamoto","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jvsv.2022.09.015_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1358863X18802007","article-title":"Risk factors associated with pain in patients with venous malformations of the extremities","volume":"24","author":"Hu","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvsv.2022.09.015_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2257.2002.00447.x","article-title":"Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome","volume":"24","author":"Mazoyer","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/pde.12373","article-title":"Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences","volume":"31","author":"Nguyen","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate\u2014a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"van Ryn","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvsv.2022.09.015_bib13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/1389200218666170427113504","article-title":"Dabigatran\u2014metabolism, pharmacologic properties and drug interactions","volume":"18","author":"Antonijevic","year":"2017","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jvsv.2022.09.015_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-200847050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jvsv.2022.09.015_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.2019000998","article-title":"Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children","volume":"135","author":"Brandao","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2022.09.015_bib16","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1160\/TH17-06-0429","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of dabigatran etexilate oral liquid formulation in infants with venous thromboembolism","volume":"117","author":"Halton","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvsv.2022.09.015_bib17","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.clinthera.2017.05.358","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses","volume":"39","author":"Almutairi","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.jvsv.2022.09.015_bib18","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1007\/s00247-015-3389-6","article-title":"MRI phenotypes of localized intravascular coagulopathy in venous malformations","volume":"45","author":"Koo","year":"2015","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2018.06.013","article-title":"Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations","volume":"168","author":"Binet","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvsv.2022.09.015_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/MBC.0000000000000666","article-title":"Successful treatment with dabigatran for consumptive coagulopathy associated with extensive vascular malformations","volume":"28","author":"Yasumoto","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jvsv.2022.09.015_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MBC.0000000000000412","article-title":"Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations","volume":"27","author":"Ardillon","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jvsv.2022.09.015_bib22","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/art.30255","article-title":"Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease","volume":"63","author":"Bogatkevich","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jvsv.2022.09.015_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/1440-1681.13668","article-title":"Expression of anti- and pro-inflammatory genes in human endothelial cells activated by 25-hydroxycholesterol: a comparison of rivaroxaban and dabigatran","volume":"49","author":"Gorzelak-Pabis","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4330\/wjc.v13.i12.710","article-title":"Dabigatran in cardiovascular disease management: a comprehensive review","volume":"13","author":"Javed","year":"2021","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/lrb.2017.0029","article-title":"Effectiveness and safety of treatment with direct oral anticoagulant rivaroxaban in patients with slow-flow vascular malformations: a case series","volume":"16","author":"Mack","year":"2018","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jvsv.2022.09.015_bib26","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MBC.0b013e3283626238","article-title":"Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban in Klippel-Trenaunay syndrome","volume":"24","author":"Randrianarisoa","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jvsv.2022.09.015_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11239-013-1024-7","article-title":"Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation","volume":"38","author":"Vandenbriele","year":"2014","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jvsv.2022.09.015_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.thromres.2022.03.004","article-title":"Is there a place for prophylaxis with DOACs in Klippel-Trenaunay syndrome and other low-flow vascular malformations with intravascular coagulopathy and thromboembolic events?","volume":"213","author":"van der Vleuten","year":"2022","journal-title":"Thromb Res"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X22004425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X22004425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:03:56Z","timestamp":1761980636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X22004425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213333X22004425"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2022.09.015","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2022.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}